Clinical Trial Update: Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of Naftin 1% Cream in adolescents with tinea cruris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Cruris

Drugs mentioned

• Naftin 1% Cream (naftifine)

Snippet

Sponsor: Merz North America, Inc. | Conditions: Tinea Cruris, Jock Itch | Phase 3 | Status: COMPLETED